Senti Biosciences, Inc. (SNTI)

Senti Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.58	48.28	35.93	57.62	56.03	30.54
Short-Term Investments	0.1	0.34	0.04	42.15	1.16	0.03
Cash & Short-Term Investments	21.67	48.61	35.97	99.77	57.19	30.56
Cash Growth	35.90%	35.15%	-63.95%	74.45%	87.13%	71.42%
Accounts Receivable	0.17	0.16	0.11	0.63	0.48	0.32
Other Receivables	3.52	1.65	17.59	-	-	-
Receivables	3.69	1.81	17.7	0.63	0.48	0.32
Prepaid Expenses	7.16	7.96	17.33	1.87	0.8	-
Other Current Assets	-	0.58	0.2	0.31	1.72	0.83
Total Current Assets	32.52	58.96	71.2	102.58	60.19	31.71
Property, Plant & Equipment	32.44	35.24	41.61	69.78	33.08	16.14
Other Long-Term Assets	3.58	3.64	6.67	8.43	3.43	0.5
Total Assets	68.54	97.84	119.48	180.79	96.7	48.35
Accounts Payable	1.02	1.45	1.25	1.37	5.19	0.91
Accrued Expenses	3.58	6.27	5.93	12.58	5.33	2
Current Portion of Leases	4.98	4.75	4.13	1.99	1.74	1.52
Current Unearned Revenue	0.36	0.66	0.99	0.8	1.66	-
Other Current Liabilities	0.05	0.01	0.38	1.32	0.63	0.44
Total Current Liabilities	9.99	13.15	12.67	18.05	14.54	4.87
Long-Term Leases	26.33	28.89	33.54	35.1	20.99	12.53
Long-Term Unearned Revenue	7.42	-	-	-	0.18	-
Other Long-Term Liabilities	0.15	5.05	6.36	0.37	0.62	-
Total Liabilities	43.89	47.09	52.57	53.53	36.33	17.4
Common Stock	0	0	0	0	-	0
Additional Paid-In Capital	350.63	322.78	311.26	300.54	3.62	1.04
Retained Earnings	-325.98	-297.13	-244.34	-173.29	-115.08	-59.76
Comprehensive Income & Other	-	-	-	0	-	-
Total Common Equity	24.65	25.65	66.91	127.26	-111.46	-58.71
Shareholders' Equity	24.65	50.76	66.91	127.26	60.38	30.95
Total Liabilities & Equity	68.54	97.84	119.48	180.79	96.7	48.35
Total Debt	31.31	33.64	37.67	37.09	22.73	14.05
Net Cash (Debt)	-9.64	14.97	-1.7	62.68	34.46	16.51
Net Cash Growth	-	-	-	81.89%	108.68%	446.97%
Net Cash Per Share	-0.85	3.26	-0.38	24.01	118.33	11.91
Filing Date Shares Outstanding	26.16	26	4.57	4.42	1.52	1.45
Total Common Shares Outstanding	26.16	4.83	4.57	4.41	1.52	1.45
Working Capital	22.53	45.82	58.53	84.53	45.65	26.84
Book Value Per Share	0.94	5.31	14.64	28.88	-73.38	-40.48
Tangible Book Value	24.65	25.65	66.91	127.26	-111.46	-58.71
Tangible Book Value Per Share	0.94	5.31	14.64	28.88	-73.38	-40.48
Machinery	8.2	8.18	8.87	8.56	5.54	3.91
Construction In Progress	-	-	-	43.89	8.05	0.23
Leasehold Improvements	22.66	22.66	22.65	1.87	0.43	0.16

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q